FREMONT, Calif., Jan. 30, 2017 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of test and burn-in equipment for semiconductors and integrated optical devices, today announced that it will be exhibiting at the SPIE Photonics West 2017 Conference January 31 – February 2 in San Francisco, CA at the Moscone Convention Center (Booth #6023).
The Company will be showcasing its solutions for both wafer level and module level burn-in and test of optical devices, including its FOX-XP next generation test and burn-in system for high volume production and early failure rate (EFR) test. SPIE is the world’s largest event focusing on photonics technologies and showcases the latest innovations across a wide range of technologies.
“We continue to be very excited about the sensor and photonics markets, which we believe will be a significant market for Aehr Test, and look forward to our first time exhibiting at Photonics West,” said Gayn Erickson, President and CEO of Aehr Test Systems. “As we’ve stated before, a key market driver for Aehr Test is the rapid automotive growth of integrated optical devices in sensors, Advanced Driver Assistance Systems (ADAS) and entertainment, which have substantially higher requirements for initial quality and long-term reliability. Other key growing markets for integrated optical devices are mobile devices, high-performance servers and data centers, where the use of optical devices for sensing and communications is increasing with every new product generation. We believe that these are extremely interesting fields that are going to drive an entirely new level of quality and reliability expectation of hardware systems and pose a very interesting long-term opportunity for the Company.”
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic and memory integrated circuits and has an installed base of more than 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, capacity needs and opportunities for Aehr Test products in package and wafer level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOXTM families of test and burn-in systems and WaferPak contactors. The ABTS systems are used in production and qualification testing of packaged parts for both low-power and high-power logic as well as memory devices. The FOX family of systems includes single and multi-wafer full wafer contact test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers and systems-on-a-chip. The WaferPak contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. For more information, please visit Aehr Test’s website at www.aehr.com.
Contacts: Aehr Test Systems Carl Buck V.P. of Marketing (510) 623-9400 x381 [email protected] MKR Group Inc. Todd Kehrli or Jim Byers Analyst/Investor Contact (323) 468-2300 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



